Mistletoe: From Mythology to Evidence-Based MedicineAvailable to Purchase
Since ancient times the mistletoe plant has been used for healing diseases. Today mistletoe extract therapy is among the most thoroughly studied complementary treatments in Europe. Several studies and meta-analyses have shown it to be beneficial for cancer patients in terms of survival, improved quality of life and minimised side effects of cancer chemotherapy. This book gives an overview of the research on mistletoe therapy from antiquity to the present. Topics discussed include the cultural and medical history of mistletoe, the diversity of the plant´s molecular constituents, and its anticancer activities including cytotoxicity and immunomodulation. A timeline of the development of mistletoe research is presented. Special attention is given to the application of mistletoe extracts as a supportive treatment in glioblastoma, after cancer surgery and in cancer-related fatigue. This timely publication is a treasure trove for oncologists devoted to a holistic tumor therapy, caregivers of cancer patients, pharmacologists interested in phytomedicine and medical historians.
Download citation file:
Digital Version
Print Version
Table of Contents
-
1 - 10: Mistletoe through Cultural and Medical History: The All-Healing Plant Proves to Be a Cancer-Specific RemedyByHartmut RammHartmut RammHiscia Institute, Society for Cancer Research, Arlesheim, SwitzerlandSearch for other works by this author on:
-
11 - 23: Chemical Constituents of Viscum album L.: Implications for the Pharmaceutical Preparation of MistletoeByKonrad Urech;Konrad UrechHiscia Institute, Society for Cancer Research, Arlesheim, SwitzerlandSearch for other works by this author on:Stephan BaumgartnerStephan BaumgartnerHiscia Institute, Society for Cancer Research, Arlesheim, SwitzerlandSearch for other works by this author on:
-
24 - 38: The Anti-Cancer Activity of Mistletoe Preparations, as Related to Their Polyphenolic ProfilesByHenning M. SchrammHenning M. SchrammInstitute Hiscia, Society for Cancer Research, Arlesheim, SwitzerlandSearch for other works by this author on:
-
39 - 47: From Berlin and Witten to Southampton and Hamburg: 25 Years of Mistletoe Research CooperationByUdo Schumacher;Udo SchumacherInstitute of Anatomy and Experimental Morphology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, GermanySearch for other works by this author on:Uwe PfüllerUwe PfüllerInstitute of Anatomy and Experimental Morphology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, GermanySearch for other works by this author on:
-
48 - 56: Mistletoe Compounds as Anti-Cancer Drugs: Effects and Mechanisms in the Treatment of GlioblastomaBySonja Schötterl;Sonja SchötterlHertie Institute for Clinical Brain Research and Center of Neurology, Department of Vascular Neurology, Laboratory of Molecular Neuro-Oncology, University of Tübingen, Tübingen, GermanySearch for other works by this author on:Ulrike NaumannUlrike NaumannHertie Institute for Clinical Brain Research and Center of Neurology, Department of Vascular Neurology, Laboratory of Molecular Neuro-Oncology, University of Tübingen, Tübingen, GermanySearch for other works by this author on:
-
57 - 66: Cancer Surgery and Supportive Mistletoe Therapy: From Scepticism to Randomised Clinical TrialsByDanijel Galun;Danijel GalunaClinic for Digestive Surgery, Clinical Center of Serbia,bMedical School, University of Belgrade, Belgrade, Serbia;Search for other works by this author on:Wilfried Tröger;Wilfried TrögercClinical Research Dr. Tröger, Freiburg, GermanySearch for other works by this author on:Miroslav MilicevicMiroslav MilicevicaClinic for Digestive Surgery, Clinical Center of Serbia,bMedical School, University of Belgrade, Belgrade, Serbia;Search for other works by this author on:
-
67 - 73: Dissecting the Anti-Inflammatory Effects of Viscum album: Inhibition of Cytokine-Induced Expression of Cyclo-Oxygenase-2 and Secretion of Prostaglandin E2BySri Ramulu Elluru;Sri Ramulu ElluruaDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden;Search for other works by this author on:Chaitrali Saha;Chaitrali SahabInstitut National de la Santé et de la Recherche Médicale, Unité 1138, Paris,cUniversité de Technologie de Compiègne, Compiègne,dCentre de Recherche des Cordeliers, Equipe-Immunopathology and Therapeutic Immunointervention, Paris,Search for other works by this author on:Pushpa Hedge;Pushpa HedgebInstitut National de la Santé et de la Recherche Médicale, Unité 1138, Paris,cUniversité de Technologie de Compiègne, Compiègne,dCentre de Recherche des Cordeliers, Equipe-Immunopathology and Therapeutic Immunointervention, Paris,Search for other works by this author on:Alain Friboulet;Alain FribouleteCNRS UMR 6022, Université de Technologie de Compiègne, Compiègne,Search for other works by this author on:Jagadeesh Bayry;Jagadeesh BayrybInstitut National de la Santé et de la Recherche Médicale, Unité 1138, Paris,dCentre de Recherche des Cordeliers, Equipe-Immunopathology and Therapeutic Immunointervention, Paris,fSorbonne Universités, UPMC Univ Paris 06, UMRS 1138, Paris,gUniversité Paris Descartes, Sorbonne Paris Cité, UMRS 1138, Paris, FranceSearch for other works by this author on:Srini V. KaveriSrini V. KaveribInstitut National de la Santé et de la Recherche Médicale, Unité 1138, Paris,dCentre de Recherche des Cordeliers, Equipe-Immunopathology and Therapeutic Immunointervention, Paris,fSorbonne Universités, UPMC Univ Paris 06, UMRS 1138, Paris,gUniversité Paris Descartes, Sorbonne Paris Cité, UMRS 1138, Paris, FranceSearch for other works by this author on:
-
74 - 81: Dancing with the Devil: Cancer-Related Fatigue, from Inflammation to Treatment OptionsByKurt S. ZänkerKurt S. ZänkerInstitute of Immunology and Experimental Oncology, Centre for Biomedical Education and Research, Department of Human Medicine, Faculty of Health Science, University Witten/Herdecke, Witten, GermanySearch for other works by this author on: